Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
autologous mesenchymal cells (1 trial)
autologous mesenchymal stem cells (1 trial)
aldesleukin (proleukin) (1 trial)
conjugate of plasmid dna with linear polyethylenimine 20 kda (pei) (1 trial)
haploidentical natural killer cell (1 trial)
lenalidomide (revlimid) (1 trial)
ss2017 (1 trial)
Acute Disease (Phase 1)
Chronic Periodontitis (Phase 2)
Gingival Recession (Phase 2)
Leukemia (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Neuroblastoma (Phase 1)
Periodontitis (Phase 2)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)
Trials (4 total)
Trial APIs (7 total)